Related Experiment Video
Updated: Feb 12, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
The therapeutic effect of splenectomy plus selective pericardial devascularization versus conventional pericardial
1Department of Pancreatic and Gastric Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Insights
Selective extrahepatic devascularization (s-EGDV) with splenectomy is more effective than non-selective extrahepatic devascularization (n-sEGDV) for treating portal hypertension, reducing complications and improving outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Oncology
- Vascular Surgery
Background:
- Portal hypertension with thoracic esophageal varices and bleeding presents significant clinical challenges.
- Current surgical strategies aim to reduce portal pressure and prevent variceal bleeding.
Purpose of the Study:
- To systematically review and meta-analyze perioperative outcomes and postoperative complications of splenectomy plus selective extrahepatic devascularization (s-EGDV) versus non-selective extrahepatic devascularization (n-sEGDV).
- To compare the efficacy and safety of s-EGDV and n-sEGDV in managing portal hypertension.
Main Methods:
- A comprehensive literature search was conducted across major databases (PubMed, Cochrane Library, Web of Science, EMBASE, TCGA, Chinese Biomedicine Database) from January 2000 to June 2017.
- Included studies were randomized controlled trials (RCTs) and non-randomized observational clinical studies (OCS) comparing s-EGDV and n-sEGDV.
- Study selection and data extraction were performed by two independent investigators.
Main Results:
- The meta-analysis included 7 RCTs and 7 OCS.
- s-EGDV demonstrated significant benefits in reducing portal vein flow (PVF), portal hypertensive gastropathy, hepatic encephalopathy, and postoperative re-bleeding and mortality.
- s-EGDV also showed an increase in hepatic artery flow compared to n-sEGDV.
Conclusions:
- Selective extrahepatic devascularization (s-EGDV) combined with splenectomy is a more effective surgical approach for treating portal hypertension compared to non-selective extrahepatic devascularization (n-sEGDV).
- s-EGDV is associated with fewer postoperative complications and improved patient outcomes.
- This approach may offer a new direction for surgical management of portal hypertension.
Background:
To systematically review perioperative outcomes and postoperative complications between splenectomy plus s-EGDV and n-sEGDV for portal hypertension complicated with thoracic esophageal varices and bleeding by a meta-analysis.
Method:
We searched the databases of PubMed, the Cochrane Library, Web of Science, EMBASE, TCGA, Chinese Biomedicine Database from January 2000 to June 2017, and included studies that compared perioperative outcomes and postoperative complications between s-EGDV and n-sEGDV. These included studies were assessed by two independent investigators.
Results:
Seven randomized controlled trials (RCTs) and seven non-randomized observational clinical studies (OCS) were included. The s-EGDV was more beneficial than n-sEGDV in reducing the PVF (OR = 4.26; 95% CI, 2.81-5.71; P < 0.00001; I2 = 97% for heterogeneity), portal vein flow (OR = -111.75; 95% CI, -197.13-26.38; P = 0.01; I2 = 90% for heterogeneity), portal hypertensive gastropathy(OR = 0.38; 95% CI, 0.28-0.51; P < 0.00001; I2 = 0% for heterogeneity), hepatic encephalopathy (OR = 0.40; 95% CI, 0.23-0.71; P = 0.002; I2 = 22% for heterogeneity), postoperative re-bleeding (OR = 0.43; 95% CI, 0.29-0.63; P < 0.0001; I2 = 9% for heterogeneity), postoperative mortality (OR = 0.52; 95% CI, 0.32-0.85; P = 0.009; I2 = 0% for heterogeneity) and in increasing hepatic artery flow (OR = 92.53; 95% CI, 9.60-175.46; P = 0.03; I2 = 95% for heterogeneity).
Conclusion:
sEGDV offers a more effective surgical approach with fewer complications to treat portal hypertension than n-sEGDV. Upon further detailed analysis of the surgical indications and hemodynamic and postoperative major complications of selective devascularization, sEGDV likely will provide us with a new direction in the choice of surgical approach for portal hypertension.
Related Concept Videos
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Sign Convention
The normal force acts perpendicular to the beam's cross-section and can...
Directing Effect of Substituents: meta-Directing Groups
Therapeutic Drug Monitoring: Drug Analysis Methods
Enolate Mechanism Conventions
Hypertension I: Introduction

